AGP Executive Report
Last update: an hour agoConsumer Health: The EU approved Kimberly-Clark’s $48.7 billion acquisition of Kenvue, owner of Neutrogena, Listerine and Tylenol. To protect competition and affordability, Kimberly-Clark must sell its feminine-hygiene brands in the European Economic Area, which includes Liechtenstein. Seasonal Viruses: Switzerland’s health office expects a flu wave around mid-December. Flu and RSV levels remain low for now, while Covid-19 cases are rising in some regions. Food Safety: Scientists have raised cancer concerns about BHA, an antioxidant increasingly used in fishmeal as an alternative to ethoxyquin. The risks relate to chemicals used in fish feed; the report notes ethoxyquin has been detected in some imported seafood in the US.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
